The intrinsic resistome of Pseudomonas aeruginosa to β-lactams

Virulence

Volumn 2, Issue 2, 2011, Pages 144-146

  Alvarez Ortega, Carolina ^a   Wiegand, Irith ^b   Olivares, Jorge ^a   Hancock, Robert E W ^c   Martínez, José Luis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b AiCuris GmbH   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Intrinsic resistance; Pseudomonas aeruginosa; Resistome; lactam resistance; lactamase

Indexed keywords

BETA LACTAM; CARBAPENEM; CEFTAZIDIME; IMIPENEM; PENICILLIN BINDING PROTEIN; PEPTIDOGLYCAN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL METABOLISM; BIOSYNTHESIS; CELL ADHESION; CELL MOTILITY; MEMBRANE PERMEABILITY; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; TRANSPOSON; BACTERIAL GENE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MICROBIOLOGY; PSEUDOMONAS INFECTION; REVIEW;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; GENES, BACTERIAL; HUMANS; MUTAGENESIS, INSERTIONAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 85011940598     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.2.15014     Document Type: Article

References (28)

1. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martinez-Solano L, et al. A global view of antibiotic resistance. FEMS Microbiol Rev 2009; 33:44-65.
2. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007; 128:1037-50.
3. Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000; 44:1771-7.
4. Davies JE. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found Symp 1997; 207:15-27.
5. D'Acosta VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science 2006; 311:374-7.
6. Benveniste R, Davies J. Aminoglycoside antibioticinactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci USA 1973; 70:2276-80.
7. Alonso A, Rojo F, Martinez JL. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol 1999; 1:421-30.
8. Martinez JL, Sanchez MB, Martinez-Solano L, Hernandez A, Garmendia L, Fajardo A, Alvarez-Ortega C. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 2009; 33:430-49.
9. Liu A, Tran L, Becket E, Lee K, Chinn L, Park E, et al. Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother 2010; 54:1393-403.
10. Tamae C, Liu A, Kim K, Sitz D, Hong J, Becket E, et al. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol 2008; 190:5981-8.
11. Schurek KN, Marr AK, Taylor PK, Wiegand I, Semenec L, Khaira BK, et al. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008; 52:4213-9.
12. Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock REW. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 2008; 52:4486-91.
13. Fajardo A, Martinez-Martin N, Mercadillo M, Galan JC, Ghysels B, Matthijs S, et al. The neglected intrinsic resistome of bacterial pathogens. PLoS ONE 2008; 3:e1619.
14. Girgis HS, Hottes AK, Tavazoie S. Genetic architecture of intrinsic antibiotic susceptibility. PLoS ONE 2009; 4:e5629.
15. Overhage J, Bains M, Brazas MD, Hancock REW. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol 2008; 190:2671-9.
16. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358:135-8.
17. Alvarez-Ortega C, Wiegand I, Olivares J, Hancock REW, Martinez JL. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother 2010; 54:4159-67.
18. Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005; 18:306-13.
19. Lister PD, Wolter DJ, Hanson ND. Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22:582-610.
20. Hancock REW, Brinkman FSL. Function of Pseudomonas porins in uptake and efflux. Ann Rev Microbiol 2002; 56:17-38.
21. Baquero F. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 2001; 4:93-105.
22. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plesiat P. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 2007; 51:1016-21.
23. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemoth 2007; 60:788-94.
24. Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 2010; 8:423-35.
25. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130:797-810.
26. De Groote VN, Verstraeten N, Fauvart M, Kint CI, Verbeeck AM, Beullens S, et al. Novel persistence genes in Pseudomonas aeruginosa identified by highthroughput screening. FEMS Microbiol Lett 2009; 297:73-9.
27. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, et al. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 2008; 190:7910-7.
28. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 2005; 49:3382-6.